Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-09-23
2008-09-23
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
10528601
ABSTRACT:
The present invention relates to novel morpholine-bridged indazole derivatives having the formulawhich stimulate soluble guanylate cyclase, to a process for the preparation thereof, and to pharmaceutical compositions containing them. These compounds are useful for the treatment of disorders of the central nervous system.
REFERENCES:
patent: 19834047 (2000-02-01), None
patent: 9816507 (1998-04-01), None
patent: 9823619 (1998-06-01), None
patent: 0006567 (2000-02-01), None
patent: 0006569 (2000-02-01), None
patent: 0021954 (2000-04-01), None
patent: 0242299 (2002-05-01), None
patent: 0242300 (2002-05-01), None
patent: 0242301 (2002-05-01), None
patent: 0242302 (2002-05-01), None
Feurer Achim
König Gerhard
Lang Dieter
Luithle Joachim
Schenke Thomas
Bayer Healthcare AG
Edwards Angell Palmer & & Dodge LLP
Habte Kahsay T
Kramer Barry
Loren Ralph
LandOfFree
Morpoline-bridged indazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morpoline-bridged indazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpoline-bridged indazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3959470